Primary aldosteronism with postoperative elevation of aldosterone treated effectively by finerenone: A case report

IF 2.7 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Cai-Guo Yu MD, Bin Cao MD, Hao-Lin Gong MD, PhD, Jing Ke MD, PhD, Shao-Zhong Xian MD, PhD, Nan-Nan Wu MD, PhD, Dong Zhao MD, PhD
{"title":"Primary aldosteronism with postoperative elevation of aldosterone treated effectively by finerenone: A case report","authors":"Cai-Guo Yu MD,&nbsp;Bin Cao MD,&nbsp;Hao-Lin Gong MD, PhD,&nbsp;Jing Ke MD, PhD,&nbsp;Shao-Zhong Xian MD, PhD,&nbsp;Nan-Nan Wu MD, PhD,&nbsp;Dong Zhao MD, PhD","doi":"10.1111/jch.14877","DOIUrl":null,"url":null,"abstract":"<p>The authors report a case of primary aldosteronism (PA) with postoperative elevation of aldosterone treated effectively by finerenone. The patient was a hypertensive man with a 30-year history of hypertension and sustained an acute myocardial infarction 5 years ago. Bilateral adrenal nodules with hyperplasia were detected and PA was confirmed. His blood potassium, direct renin concentration, and aldosterone level returned to normal after surgery of right adrenalectomy. However, 1 year after surgery, he experienced a decrease in blood potassium and an increase in aldosterone. A saline infusion test revealed an aldosterone level of 124.47 pg/mL. The patient consented to treatment with finerenone. His aldosterone and potassium levels and blood pressure have been controlled well during follow-up. This case highlights the need to screen for secondary hypertension as early as possible. Finerenone may be effective for patients with PA who are not candidates for surgery and those not relieved after surgery.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":"26 9","pages":"1116-1120"},"PeriodicalIF":2.7000,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.14877","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.14877","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

The authors report a case of primary aldosteronism (PA) with postoperative elevation of aldosterone treated effectively by finerenone. The patient was a hypertensive man with a 30-year history of hypertension and sustained an acute myocardial infarction 5 years ago. Bilateral adrenal nodules with hyperplasia were detected and PA was confirmed. His blood potassium, direct renin concentration, and aldosterone level returned to normal after surgery of right adrenalectomy. However, 1 year after surgery, he experienced a decrease in blood potassium and an increase in aldosterone. A saline infusion test revealed an aldosterone level of 124.47 pg/mL. The patient consented to treatment with finerenone. His aldosterone and potassium levels and blood pressure have been controlled well during follow-up. This case highlights the need to screen for secondary hypertension as early as possible. Finerenone may be effective for patients with PA who are not candidates for surgery and those not relieved after surgery.

Abstract Image

原发性醛固酮增多症,术后醛固酮升高,非奈酮治疗有效:病例报告。
作者报告了一例原发性醛固酮增多症(PA)患者,术后醛固酮升高,非奈酮治疗有效。患者是一名有 30 年高血压病史的男性,5 年前曾患急性心肌梗死。发现双侧肾上腺结节增生,并确诊为 PA。右侧肾上腺切除手术后,他的血钾、直接肾素浓度和醛固酮水平恢复正常。然而,术后一年,他的血钾下降,醛固酮升高。生理盐水输注试验显示醛固酮水平为 124.47 pg/mL。患者同意接受非格列酮治疗。随访期间,他的醛固酮和血钾水平以及血压控制良好。本病例强调了尽早筛查继发性高血压的必要性。非格列酮可能对不适合手术的 PA 患者和术后症状未缓解的患者有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Hypertension
Journal of Clinical Hypertension PERIPHERAL VASCULAR DISEASE-
CiteScore
5.80
自引率
7.10%
发文量
191
审稿时长
4-8 weeks
期刊介绍: The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信